Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2) : 12-month results from a randomised, double-masked, phase 3 trial

Khanani Arshad M and Patel Sunil S and Staurenghi Giovanni and Tadayoni Ramin and Danzig Carl J and Eichenbaum David A and Hsu Jason and Wykoff Charles C and Heier Jeffrey S and Lally David R and Monés Jordi and Nielsen Jared S and Sheth Veeral S and Kaiser Peter K and Clark Julie and Zhu Liansheng and Patel Hersh and Tang Justin and Desai Dhaval and Jaffe Glenn J and Kollaborációs szervezet: GATHER2 trial investigators and Tóth-Molnár Edit (kollab. közrem.): Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2) : 12-month results from a randomised, double-masked, phase 3 trial.
LANCET, 402 (10411). pp. 1449-1458. ISSN 0140-6736 (2023)

[thumbnail of 34521369.pdf] Text
34521369.pdf - Published Version

Download (587kB)
Item Type: Journal Article
Szerzők száma: 204
Journal or Publication Title: LANCET
Date: 2023
Volume: 402
Number: 10411
Page Range: pp. 1449-1458
ISSN: 0140-6736
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34521369
DOI azonosító: https://doi.org/10.1016/S0140-6736(23)01583-0
Date Deposited: 2024. Jan. 22. 09:04
Last Modified: 2024. Jan. 22. 09:04
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/29365
Web of Science® Times Cited: 38 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year